Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 19 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 10 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

Phase 1
10(52.6%)
Early Phase 1
5(26.3%)
N/A
2(10.5%)
Phase 2
2(10.5%)
19Total
Phase 1(10)
Early Phase 1(5)
N/A(2)
Phase 2(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (19)

Showing 19 of 19 trials
NCT07355868Early Phase 1Recruiting

Treatment of Chronic Obstructive Pulmonary Disease (COPD) by REGEND007 Cell Therapy

Role: lead

NCT06081621Phase 2Completed

A Clinical Study to Evaluate the Efficacy and Safety of REGEND001 Cell Therapy on Idiopathic Pulmonary Fibrosis (IPF)

Role: lead

NCT07275788Phase 1Recruiting

A Study of REGEND003 on Patients With Type 2 Diabetes Mellitus (T2DM) and Chronic Kidney Disease (CKD)

Role: lead

NCT07359963Early Phase 1Not Yet Recruiting

Treatment of Idiopathic Pulmonary Fibrosis (IPF) by REGEND007 Cell Therapy

Role: lead

NCT07239895Early Phase 1Recruiting

Treatment of Pediatric Bronchiolitis Obliterans by Airway Basal Stem Cells

Role: lead

NCT05638776Phase 2Completed

Treatment of Chronic Obstructive Pulmonary Disease (COPD) With Diffusion Capacity Defect by REGEND001 Cell Therapy

Role: lead

NCT06164093Not ApplicableCompleted

Follow-up Study of Autologous Transplantation of P63+ Lung Progenitor Cells for Treatment of Bronchiectasis

Role: collaborator

NCT05657184Phase 1Completed

Treatment of Idiopathic Pulmonary Fibrosis (IPF) by REGEND001

Role: lead

NCT03655808Phase 1Completed

Autologous Transplantation of Bronchial Basal Cells for Treatment of Bronchiectasis

Role: collaborator

NCT02796781Phase 1Completed

Autologous Lung Stem Cell Transplantation in Patients With Interstitial Lung Diseases

Role: collaborator

NCT05594303Phase 1Completed

COPD Treatment by Transplantation of Autologous Bronchial Basal Cells

Role: collaborator

NCT02745184Phase 1Completed

Clinical Efficacy and Safety of Autologous Lung Stem Cell Transplantation in Patients With Idiopathic Pulmonary Fibrosis

Role: collaborator

NCT03188627Phase 1Completed

Autologous Bronchial Basal Cell Transplantation for Treatment of COPD

Role: lead

NCT03021681Not ApplicableCompleted

An Exploratory Study on the Treatment of Chronic Obstructive Pulmonary Disease With Autologous Bronchial Basal Cell Transplantation

Role: collaborator

NCT02722642Phase 1Unknown

Autologous Bronchial Basal Cells Transplantation for Treatment of Bronchiectasis

Role: lead

NCT03153800Early Phase 1Unknown

Autologous Bronchial Basal Cells Transplantation for Treatment of CRD Including COPD, BE and PF

Role: lead

NCT03655795Phase 1Unknown

Autologous Transplantation of Bronchial Basal Cells for Treatment of COPD

Role: collaborator

NCT03156673Early Phase 1Unknown

Treatment of COPD by Autologous Transplantation of Bronchial Basal Cells

Role: collaborator

NCT03092648Phase 1Unknown

Autologous Bronchial Basal Cells Transplantation for Treatment of Chronic Obstructive Pulmonary Disease (COPD)

Role: collaborator

All 19 trials loaded